---
title: "Autobio released its 2024 annual performance, with a net profit attributable to the parent company of 1.194 billion yuan, a year-on-year decrease of 1.89%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236376996.md"
description: "According to the Zhitong Finance APP, Autobio disclosed its 2024 annual report, stating that the company achieved revenue of 4.471 billion yuan during the reporting period, a year-on-year increase of 0.62%; net profit attributable to shareholders was 1.194 billion yuan, a year-on-year decrease of 1.89%; net profit excluding non-recurring items was 1.099 billion yuan, a year-on-year decrease of 7.30%; basic earnings per share were 2.07 yuan. The company plans to distribute a cash dividend of 1.26 yuan per share (tax included) to all shareholders"
datetime: "2025-04-17T09:04:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236376996.md)
  - [en](https://longbridge.com/en/news/236376996.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236376996.md)
generator: "portal-rs"
---

# Autobio released its 2024 annual performance, with a net profit attributable to the parent company of 1.194 billion yuan, a year-on-year decrease of 1.89%

According to the Zhitong Finance APP, Autobio (603658.SH) disclosed its annual report for 2024. During the reporting period, the company achieved revenue of 4.471 billion yuan, a year-on-year increase of 0.62%; the net profit attributable to shareholders was 1.194 billion yuan, a year-on-year decrease of 1.89%; the net profit excluding non-recurring items was 1.099 billion yuan, a year-on-year decrease of 7.30%; basic earnings per share were 2.07 yuan. The company plans to distribute a cash dividend of 1.26 yuan per share (including tax) to all shareholders

### Related Stocks

- [603658.CN](https://longbridge.com/en/quote/603658.CN.md)

## Related News & Research

- [RemeGen files board, board committee member list with disclosure responsibilities](https://longbridge.com/en/news/296803857.md)
- [Sappi, UPM propose graphic paper joint venture](https://longbridge.com/en/news/297161466.md)
- [AFYREN scales bio-based acid output and strengthens climate-resilient positioning](https://longbridge.com/en/news/297214424.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [14:02 ETProject Lifesaver Partners With FaceTec to Identify At-Risk Children and Adults](https://longbridge.com/en/news/297076808.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**